Search
Powered By HealthLine
Special Offers
Health Tools
 Depression Basics
 Antidepressant Drug Info
 Depression Q&A
 Depression Support Groups
 Depression Related Disorders
Featured Conditions
 Depression
 Anxiety
 Sleep
 Bipolar
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Anti-Smoking Drugs Get FDA 'Black-Box' Warning


Related Encyclopedia
 border=
Acidophilus
Acne
Adenocarcinoma of the Lung and Brain Metastases
Angina Pectoris
More...

Related Healthscout Videos
 border=
Optimistic Healing
Cancer Treatment for Any Size
Fever Kills Cancer
Pinpointing Mental Illness
More...

Related Animations
 border=
Bipolar Disorder Animation
Breast Self-Exam Video
Colon Cancer
Depression
More...

Related Drug Information
 border=
Adderal XR
Ambien
Avandia
Concerta
More...

Related News Articles
 border=
Drugs Provide Same Benefit as Angioplasty for Diabetics, at Lower Cost
Study: Migraine Raises Risk of Stroke
Link Between Alzheimer's and Heart Failure
Study: Phthalate Exposure Impacts Boys
More...


Page:  << Prev | 1 | 2

Some patients who were using the drugs experienced the side effects while they were still smoking, the agency said.

Rosebraugh said the risk of using these drugs needs to be balanced with the substantial benefits of quitting smoking, and these drugs can be very effective.

"Stopping smoking is a goal we all want to work towards, and if people need medication to do it they should have access to it. So we don't want to scare people off from trying to use a medication to stop smoking; we just want them to be carefully monitored," he said.

Text Continues Below



In addition to the warning, the FDA is requesting more prescribing information in the warning section of the label, and new information in the Medication Guide for patients that discusses the risk of mental health events while using these products.

The makers of the drugs will also be required to do a clinical trial to see how often serious psychiatric symptoms occur in patients using a variety of therapies to help them quit smoking, including patients who currently have psychiatric disorders, Rosebraugh said. Results of this trial won't be known for several years, he added.

Chantix is manufactured by Pfizer Inc. Zyban is made by GlaxoSmithKline.

"The labeling update underscores the important role of health-care providers in treating smokers attempting to quit and provides specific information about Chantix and instructions that physicians and patients should follow closely," Dr. Briggs W. Morrison, senior vice president for the Primary Care Development Group at Pfizer, said in a prepared statement. "Quitting smoking is one of the best things people can do for their health, but the quitting process is both difficult and complex."

The FDA's review of consumers using nicotine patches did not find a link between patches and psychiatric side effects.

The antidepressant Wellbutrin, which contains the same active ingredient as Zyban, already carries a black-box warning.

More information

For more on how to quit smoking, visit the U.S. Centers for Disease Control and Prevention.

Page:  << Prev | 1 | 2

Copyright © 2009 ScoutNews, LLC. All rights reserved.
Last updated 7/1/2009

Related Links
 border=
From Healthscout's partner site on depression, MyDepressionConnection.com
UNDERSTAND: Get a full understanding of depression
TREATMENT: Learn how therapy and lifestyle changes can help
DRUGS: Common drugs used to treat depression





SOURCE: July 1, 2009, teleconference with Curt Rosebraugh, M.D., M.P.H., director, Office of Drug Evaluation II, U.S. Food and Drug Administration


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy: Updated as of April 1, 2009  Terms of Service   Site Map
Advertising Policy